Rate of decline of forced vital capacity predicts future arterial hypertension: The Coronary Artery Risk Development in Young Adults Study

Hypertension

Volumn 59, Issue 2, 2012, Pages 219-225

  Jacobs, David R ^a   Yatsuya, Hiroshi ^c   Hearst, Mary O ^a   Thyagarajan, Bharat ^b   Kalhan, Ravi ^d   Rosenberg, Sharon ^d   Smith, Lewis J ^d   Barr, R Graham ^e   Duprez, Daniel A ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adults; CARDIA; Cohort; Forced vital capacity; Hypertension

Indexed keywords

ADULT; ARTICLE; ASTHMA; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY; DEMOGRAPHY; FEMALE; FORCED VITAL CAPACITY; HUMAN; HYPERTENSION; INCIDENCE; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SPIROMETRY; TIME FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 84856247308     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.184101     Document Type: Article

References (38)

1. Dawber TR, Kannel WE, Friedman GD. Vital capacity, physical activity and coronary heart disease. In: Roab W, ed. Prevention of Ischemic Heart Disease: Principles and Practice. Springfield, IL: Charles C. Thomas Publisher Ltd, 1966;254-265.
2. Higgins MW, Keller JB. Predictors of mortality in the adult population of Tecumseh. Arch Environ Health. 1970;21:418-424.
3. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley Prospective Population Study. BMJ. 1996;313:711-716. (Pubitemid 26313070)
4. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000;118:656-664.
5. Hozawa A, Billings JL, Shahar E, Ohira T, Rosamond WD, Folsom AR. Lung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities Study. Chest. 2006;130:1642-1649. (Pubitemid 46033414)
6. Vestbo J, Lange P. Forced expiratory volume in 1 second (FEV1)-a respiratory physiological measurement of considerable prognostic value [in Danish] Ugeskr Laeger. 1991;153:2292-2295.
7. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J. 1991;4:1080-1087.
8. Engström G, Olle M, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalizations. Thorax. 2010;65:633-638.
9. Wu Y, Vollmer WM, Buist AS, Tsai R, Cen R, Wu X, Chen P, Li Y, Guo C, Mai J, Davis CE. Relationship between lung function and blood pressure in Chinese men and women of Beijing and Guangzhou: PRC-USA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Int J Epidemiol. 1998;27:49-56. (Pubitemid 28140502)
10. Truelsen T, Prescott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke: the Copenhagen City Heart Study. Int J Epidemiol. 2001;30:145-151. (Pubitemid 32203804)
11. Engstrom G, Wollmer P, Valind S, Hedblad B, Janzon L. Blood pressure increase between 55 and 68 years of age is inversely related to lung function: longitudinal results from the cohort study 'Men born in 1914.' J Hypertens. 2001;19:1203-1208. (Pubitemid 32595275)
12. Sparrow D, Weiss ST, Vokonas PS, Cupples LA, Ekerdt DJ, Colton T. Forced vital capacity and the risk of hypertension: the Normative Aging Study. Am J Epidemiol. 1988;127:734-741.
13. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105-1116. (Pubitemid 19039041)
14. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med. 1995;152:1107-1136.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J, ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005;26:319-338. (Pubitemid 41079078)
16. Standardization of spirometry: 1987 update.-statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136:1285-1298.
17. ATS statement: snowbird workshop on standardization of spirometry. Am Rev Respir Dis. 1979;119:831-838.
18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. (Pubitemid 37553153)
19. Sidney S, Jacobs DR Jr, Haskell WL, Armstrong MA, Dimicco A, Oberman A, Savage PJ, Slattery ML, Sternfeld B, Van Horn L. Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol. 1991;133:1231-1245.
20. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Resp J. 1999;13:197-205. (Pubitemid 29079244)
21. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653. (Pubitemid 38787999)
22. Stanescu D. Small airways obstruction syndrome. Chest. 1999;116:231-233. (Pubitemid 29340287)
23. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278:1355-1360.
24. Taylor BJ; Johnson BD. The pulmonary circulation and exercise responses in the elderly. Semin Respir Crit Care Med. 2010;31:528-538.
25. Peralta CA, Adeney KL, Shlipak MG, Jacobs D Jr, Duprez D, Bluemke D, Polak J, Psaty B, Kestenbaum BR. Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2010;171:63-71.
26. Thyagarajan B, Jacobs DR Jr, Apostol GG, Smith LJ, Jensen RL, Crapo RO, Barr RG, Lewis CE, Williams OD. Longitudinal association of body mass index with lung function: the CARDIA Study. Respir Res. 2008;9:31.
27. Engström G, Hedblad B, Nilsson P, Wollmer P, Berglund G, Janzon L. Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med. 2003;253:5574-5581.
28. Kalhan R, Tran BT, Colangelo LA, Rosenberg SR, Liu K, Thyagarajan B, Jacobs DR Jr, Smith LJ. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010;5:e11431.
29. Thyagarajan B, Smith LJ, Barr RG, Gross MD, Sood A, Kalhan R, Jacobs DR Jr. Association of circulating adhesion molecules with lung function: the CARDIA study. Chest. 2009;135:1481-1487.
30. Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD. Plasma fibrinogen and lung function: the CARDIA Study. Int J Epidemiol. 2006;35:1001-1008. (Pubitemid 44540754)
31. Engström G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgärde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555-2560. (Pubitemid 35340691)
32. Duprez DA, Somasundaram PE, Sigurdsson G, Hoke L, Florea N, Cohn JN. Relationship between C-reactive protein and arterial stiffness in an asymptomatic population. J Hum Hypertens. 2005;19:515-519. (Pubitemid 40946035)
33. Murphy DM, O'Byrne PM. Recent advances in the pathophysiology of asthma. Chest. 2010;137:1417-1426.
34. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, Shimbo D, Stevenson L. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med. 2007;176:1200-1207. (Pubitemid 350256473)
35. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, Breen L, Wilkinson IB, McEniery CM, Donaldson K, Newby DE, Macnee W. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax. 2008;63:306-311. (Pubitemid 351497941)
36. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, Newby DE, Murchison JT, Macnee W. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176:1208-1214. (Pubitemid 350256474)
37. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvàth T, Jiang H, Sorrentino SA, Steenken N, Manes C, Marzilli M, Rudolph KL, Lüscher TF, Drexler H, Landmesser U. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55:1389-1397.
38. Engström G, Gerhardsson de Verdier M, Dahlbäck M, Janson C, Lind L. BP variability and cardiovascular autonomic function in relation to forced expiratory volume: a population-based study. Chest. 2009;136:177-183.